149 related articles for article (PubMed ID: 36084850)
1. TRIM56 impairs HBV infection and replication by inhibiting HBV core promoter activity.
Tian X; Dong H; Lai X; Ou G; Cao J; Shi J; Xiang C; Wang L; Zhang X; Zhang K; Song J; Deng J; Deng H; Lu S; Zhuang H; Li T; Xiang K
Antiviral Res; 2022 Nov; 207():105406. PubMed ID: 36084850
[TBL] [Abstract][Full Text] [Related]
2. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
[TBL] [Abstract][Full Text] [Related]
3. Tripartite Motif-Containing Protein 65 (TRIM65) Inhibits Hepatitis B Virus Transcription.
Shen S; Yan R; Xie Z; Yu X; Liang H; You Q; Zhang H; Hou J; Zhang X; Liu Y; Sun J; Guo H
Viruses; 2024 May; 16(6):. PubMed ID: 38932182
[TBL] [Abstract][Full Text] [Related]
4. Overlapping and distinct molecular determinants dictating the antiviral activities of TRIM56 against flaviviruses and coronavirus.
Liu B; Li NL; Wang J; Shi PY; Wang T; Miller MA; Li K
J Virol; 2014 Dec; 88(23):13821-35. PubMed ID: 25253338
[TBL] [Abstract][Full Text] [Related]
5. The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.
Liu B; Li NL; Shen Y; Bao X; Fabrizio T; Elbahesh H; Webby RJ; Li K
J Virol; 2016 May; 90(9):4369-4382. PubMed ID: 26889027
[TBL] [Abstract][Full Text] [Related]
6. TRIM56 overexpression restricts porcine epidemic diarrhoea virus replication in Marc-145 cells by enhancing TLR3-TRAF3-mediated IFN-β antiviral response.
Xu X; Wang L; Liu Y; Shi X; Yan Y; Zhang S; Zhang Q
J Gen Virol; 2022 May; 103(5):. PubMed ID: 35503719
[TBL] [Abstract][Full Text] [Related]
7. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
[TBL] [Abstract][Full Text] [Related]
8. Key roles for phosphorylation and the Coiled-coil domain in TRIM56-mediated positive regulation of TLR3-TRIF-dependent innate immunity.
Liu BM; Li NL; Wang R; Li X; Li ZA; Marion TN; Li K
J Biol Chem; 2024 May; 300(5):107249. PubMed ID: 38556084
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO.
Wang Y; Cui L; Yang G; Zhan J; Guo L; Chen Y; Fan C; Liu D; Guo D
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404796
[TBL] [Abstract][Full Text] [Related]
10. TRIM56-mediated production of type I interferon inhibits intracellular replication of
Cheng R; Zhou C; Zhao M; Zhang S; Wan W; Yu Y; Wen B; Jiao J; Xiong X; Xu Q; OuYang X
Microbiol Spectr; 2024 Apr; 12(4):e0369523. PubMed ID: 38358243
[TBL] [Abstract][Full Text] [Related]
11. Tripartite motif-containing protein 21 is involved in IFN-γ-induced suppression of hepatitis B virus by regulating hepatocyte nuclear factors.
Won J; Kang HS; Kim NY; Dezhbord M; Marakkalage KG; Lee E-H; Lee D; Park S; Kim D-S; Kim K-H
J Virol; 2024 Jun; 98(6):e0046824. PubMed ID: 38780244
[TBL] [Abstract][Full Text] [Related]
12. Type I IFN augments IL-27-dependent TRIM25 expression to inhibit HBV replication.
Tan G; Xiao Q; Song H; Ma F; Xu F; Peng D; Li N; Wang X; Niu J; Gao P; Qin FX; Cheng G
Cell Mol Immunol; 2018 Mar; 15(3):272-281. PubMed ID: 28194021
[TBL] [Abstract][Full Text] [Related]
13. DNA-dependent activator of interferon-regulatory factors inhibits hepatitis B virus replication.
Chen QY; Liu YH; Li JH; Wang ZK; Liu JX; Yuan ZH
World J Gastroenterol; 2012 Jun; 18(22):2850-8. PubMed ID: 22719196
[TBL] [Abstract][Full Text] [Related]
14. Intracellular interferon signalling pathways as potential regulators of covalently closed circular DNA in the treatment of chronic hepatitis B.
Goh ZY; Ren EC; Ko HL
World J Gastroenterol; 2021 Apr; 27(14):1369-1391. PubMed ID: 33911462
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus sensitivity to interferon-α in hepatocytes is more associated with cellular interferon response than with viral genotype.
Shen F; Li Y; Wang Y; Sozzi V; Revill PA; Liu J; Gao L; Yang G; Lu M; Sutter K; Dittmer U; Chen J; Yuan Z
Hepatology; 2018 Apr; 67(4):1237-1252. PubMed ID: 29059468
[TBL] [Abstract][Full Text] [Related]
16. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain.
Gao B; Duan Z; Xu W; Xiong S
Hepatology; 2009 Aug; 50(2):424-33. PubMed ID: 19585648
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives.
Huang TJ; Yang CL; Kuo YC; Chang YC; Yang LM; Chou BH; Lin SJ
Bioorg Med Chem; 2015 Feb; 23(4):720-8. PubMed ID: 25600408
[TBL] [Abstract][Full Text] [Related]
18. TRIM56 is a virus- and interferon-inducible E3 ubiquitin ligase that restricts pestivirus infection.
Wang J; Liu B; Wang N; Lee YM; Liu C; Li K
J Virol; 2011 Apr; 85(8):3733-45. PubMed ID: 21289118
[TBL] [Abstract][Full Text] [Related]
19. TRIM56 is an essential component of the TLR3 antiviral signaling pathway.
Shen Y; Li NL; Wang J; Liu B; Lester S; Li K
J Biol Chem; 2012 Oct; 287(43):36404-13. PubMed ID: 22948160
[TBL] [Abstract][Full Text] [Related]
20. HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes.
Alfaiate D; Lucifora J; Abeywickrama-Samarakoon N; Michelet M; Testoni B; Cortay JC; Sureau C; Zoulim F; Dény P; Durantel D
Antiviral Res; 2016 Dec; 136():19-31. PubMed ID: 27771387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
